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1. Introduction 
Infections in the respiratory tract are very common but majority involve the upper 
respiratory system. Pneumonia is usually caused by inhalation of infecting organisms or the 
same may reach the lung via bloodstream. Pulmonary pathogens can cause tissue damage 
by a direct invasive cytolytic process or by releasing toxins (endotoxins and/or exotoxins). 
Acute inflammation may lead to complete resolution, destructive pneumonia with abscess 
formation, healing by fibrosis or chronic inflammation. Various infective agents causing 
pneumonia include viruses, bacteria, Mycobacteria, fungi, Chlamydiae, Mycoplasmas or 
parasites. 
The diagnosis of various pulmonary infections is initially based on radiological evaluation 
depending upon chest X-ray, CT scan or MRI (magnetic resonance imaging). Cytological 
techniques used for detection of pulmonary infections include sputum examination, 
bronchial washing & brushing, bronchoalveolar lavage, transbronchial/ transthoracic fine 
needle aspiration (FNA) and EUS (endoscopic ultrasonography) guided FNA. 
Transbronchial lung biopsies are performed for histopathological detection of various 
infections and for histological evidence of invasion. Tissue can be obtained by these 
techniques for culture or other molecular diagnostic techniques such as polymerase chain 
reaction (PCR). Special stain most commonly used for bacteria is Gram’s stain and for fungi 
are Gomori's methenamine silver (GMS), Gridley's fungus (GF), and periodic acid-Schiff 
(PAS) stains.  
2. Viral infection 
Various viruses implicated in viral pneumonia include influenza, parainflenza, adenovirus, 
coxsackie, echovirus, varicella, vaccinia and measles. Most viral pneumonias are mild, but may 
be more severe or may be complicated by secondary bacterial infection.1 Microscopically, 
there may be a diffuse pan-lobular pneumonia characterised by extensive proteinaceous 
exudative material in alveoli with alveolar wall thickening and infiltration by lymphocytes. 
Hyaline membranes can be formed lining the alveoli. There may be focal interstitial 
pneumonia. Cytomegalovirus infection is characterised by cytomegaly with a large 
eosinophilic intranuclear inclusion surrounded by a pale halo giving an owl’s eye 
appearance.2 Herpes Simplex Virus (HSV) pneumonia is characterized by intranuclear 
inclusions with nucleomegaly and basophilic ground-glass alterations in the nucleoplasm.3 
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3. Bacterial infection 
The bacterial infection in lung usually starts with the introduction of organisms into the 
airways. The routes by which bacteria can reach air spaces are inhalation of an aerosol, 
aspiration of respiratory or gastrointestinal secretions, or bacteraemic spread.4,5 The 
common bacilli include Streptococcus pneumoniae, Haemophilus influenzae, anaerobic bacteria, 
Staphylococcus aureus, enteric gram-negative bacilli, Pseudomonas spp., Acinetobacter spp., 
Mycobacterium tuberculosis and Legionelia spp.  
This usually leads to acute inflammation characterized by sheets of polymorphonuclear 
neutrophils (figure 1), histiocytes, nuclear debris and necrosis which results in tissue 
destruction in the form of extensive necrotizing pneumonia with lung abscesses. Long- 
standing infection can lead to nonspecific chronic inflammation predominated by 
lymphocytes and histiocytes. Chronic pneumonia is most commonly caused by 
Mycobacteria and fungi. Actinomyces spp., Nocardia spp., and Pseudomonas pseudomallei can 
produce such infections. Legionnaire’s disease is an acute respiratory infection caused by 
Legionella pneumophila, which stains best in tissue with a silver-based Dieterle stain rather 
than a Gram stain. Organising pneumonia is characterised by intra-alveolar proliferation of 
fibroblasts producing nodular structures called Masson bodies. 
 
Fig. 1. Sheets of acute inflammatory cells in suppurative inflammation (MGG, 10X) 
3.1 Granulomatous inflammation 
Granulomatous Inflammation is characterized by collection of epithelioid histiocytes and 
multinucleated giant cells. These epithelioid cells may have an elongated cone like shapes or 
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may look like tiny carrots in sputum. These need to be differentiated from bronchial 
epithelial cells as these are elongated columnar cells which can mimic epithelioid cells.6  
Tuberculosis (TB) 
TB can involve various organs but the most common organ involved is lung. TB is more 
common in the Third World/ developing countries and is much rarer in Western Europe 
and North America. Primary pulmonary TB usually affects the lower lobes of lung or the 
anterior segment of an upper lobe, known as the Ghon focus. Microscopically, there are 
caseating epithelioid granulomas with Langhan’s type of multinucleated giant cells and 
lymphocytes (figure 2 & 3).7 In tuberculosis, epithelioid histiocytes may be found in about 
25% to 50% of sputum specimens.8 Mycobacteria are identified as elongated beaded acid-
fast bacilli (AFB) by Ziehl-Neelsen staining. Auramine-rhodamine stain is another 
fluorescent dye used to identify these bacilli. Microbiological culture is done using 
Lowenstein-Jensen medium or Bactec culture. The necrotizing granulomas may be seen in 
fungal infections or Wegener’s granulomatosis. Sarcoidosis is characterised by non-
caseating epithelioid granulomas. Secondary pulmonary TB is usually due to re-infection 
and the lesion is almost always found in the subapical region of an upper lobe. Miliary TB 
results from seeding of the bacilli via the bloodstream.  
 
 
 
 
Fig. 2. Epithelioid cell collection and lymphocytes forming a granuloma (MGG, 40X) 
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Fig. 3. Epithelioid cell collections in a case of tuberculosis (H&E, 40X) 
4. Fungal infections 
Fungi are eukaryotic, unicellular to multicellular, or filamentous organisms, that are 
ubiquitous in nature. The incidence of fungal infections is increased over the last two 
decades mostly because of increase in immunocompromised patients.9 The incidence of 
fungal infections in solid organ transplant recipients is between 5-42% and in bone marrow 
transplant recipients, the incidence ranges between 15-25% with Aspergillus, Cryptococcus 
and Candida being the most common fungal infections in these patients.10,11 
Fungi can elicit various types of tissue reactions such as acute inflammatory, necrosis, 
granulomatous inflammation. The ability to cause disease depends upon the virulence and 
the dose of the fungus, the route of infection, immunological status of the host and the organ 
affected. Lung is one of the most commonly affected organs by opportunistic fungal 
infections. Majority of the lung infections begin by inhalation of aerosolized fungi from the 
surrounding environment.12 The fungi causing invasive pulmonary infection can be primary 
and opportunistic type of fungi. The primary fungal infection occurs in healthy 
immunocompetent individuals and the opportunistic fungal infections are common in 
immunocompromised hosts.  
4.1 Aspergillosis 
The range of disease caused by fungi of the genus Aspergillus include- allergic 
bronchopulmonary disease, colonization of lung cavities/ intracavitory aspergilloma, 
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chronic necrotizing bronchial aspergillosis (CNBA), chronic necrotizing pulmonary 
aspergillosis (CNPA) in mildly immunocompromised individuals and fulminant invasive 
pulmonary aspergillosis (IPA) with systemic involvement in severely immunocompromised 
patients.13,14 A fumigatus (most common), A flavus, A niger, and other Aspergillus spp. are the 
common species causing pulmonary infections.15  
Allergic pulmonary reactions occur due to hypersensitivity to Aspergillus antigens 
especially in patients of bronchial asthma. These include allergic bronchopulmonary 
aspergillosis, chronic eosinophillic pneumonia, eosinophillic bronchiolitis, mucoid 
impaction of proximal bronchi or bronchocentric granulomatosis.16,17 On microscopy, there 
is an excess of eosinophillic infiltration with Charcot-Leyden crystals, mucus hypersecretion 
and destructive granulomatous inflammation with degenerated fungal hyphae.16 
Pulmonary aspergilloma or fungal/ mycotic ball is a compact mass of fungal hyphae 
colonizing pre-existing pulmonary cavity.14 The cavity may be due to tuberculosis, 
sarcoidosis, necrotic pulmonary malignancy, bronchiectasis or a bronchial cyst.18 Majority of 
the patients develop hemoptysis and the diagnosis is suspected after radiologic detection of 
thick walled pulmonary cavity with intracavitory mass and a positive serum precipitin 
reaction to Aspergillus antigen.19   
Chronic necrotizing bronchial aspergillosis (CNBA) includes superficial extensive 
infection of mucosal surface of bronchi resulting in mucosal erosion and ulceration with 
formation of pseudo-membranes. The patients usually present with wheezing, non-
productive cough and dyspnea. 
Chronic necrotizing pulmonary aspergillosis (CNPA) is a progressive and destructive 
lesion in mildly immunocompromised individuals with non-cavitary structural lung disease 
such as sarcoidosis, chronic pulmonary obstructive disease, postradiation fibrosis, diabetes 
mellitus, tuberculosis, and pneumoconiosis etc. Majority of these patients have history of 
treatment with low-dose corticosteroids.20 Treatment includes surgical resection or 
antifungal therapy with drainage of the pulmonary cavity. 
Invasive pulmonary aspergillosis (IPA) is a fulminant infection in severely 
immunocompromised hosts. Vascular invasion is the hallmark of this condition and leads to 
thrombotic occlusion of arteries and veins. Chest X-ray shows patchy, multifocal or diffuse 
areas of consolidation, or wedge shaped pleura based infarct like infiltrates or miliary 
nodules.21 On microscopy, the nodular infarcts are composed of central ischemic necrosis, 
surrounded by fibrinous exudates and a peripheral zone of hemorrhage forming a target 
lesion. Fungal hyphae invade by radial growth and extend from a central occluded vessel. 
Occlusion of larger vessels lead to formation of wedge shaped pleura-based haemorrhagic 
infarcts. Disseminated systemic infection occurs in a quarter of patients with IPA involving 
gastrointestinal tract, central nervous system, kidneys, heart, liver, spleen and thyroid 
gland.22    
On microscopic examination, the hyphae of the Aspergillus spp. are uniform, narrow (3-6µm 
in width), septate with regular, progressive and dichotomous branching usually at acute 
angles (45º angle) from the parent hyphae (figure 4). Conidiophores (fruiting bodies) are 
seen in lesions exposed to air such as pulmonary/ bronchial lesions. The fungal infection 
may result in necrotizing or granulomatous inflammation (figure 5) and sometimes is 
associated with Splendore- Hoeppli phenomenon.  
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Fig. 4. A long septate hyphae with parallel cell walls of aspergillus in a necrotic background 
(MGG, 40X) 
 
Fig. 5. Occasional hyphae of aspergillus in the multinucleated giant cell (MGG, 40X) 
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Differential diagnosis- The main differential diagnosis of Aspergillus includes zygomycetes, 
Pseudoallescheria boydii, the Fusarium spp. and occasionally Candida spp. 
Treatment- Amphotericin B is the drug of choice followed by Itraconazole or Voriconazole. 
Localized infections or aspergilloma may be subjected to surgical excision. 
4.2 Mucormycosis (Zygomycosis) 
Mucormycosis is an opportunistic infection that occurs in immunocompromised hosts 
especially in patients with acute leukemia or lymphoma, patients treated with 
corticosteroids, cytotoxic drugs or antibiotic therapy or patients with relapse of an 
underlying pulmonary disease.23,24 The agents of mucormycosis include species within the 
genera Rhizopus, Absidia, Mucor, Rhizomucor, Saksenaea, Cunninghamella, Mortierella, 
Syncephalastrum, and Apophysomyces. These fungi are widely distributed and the infection is 
acquired by exposure to their sporangiospores. The patients usually present with fever and 
progressive pulmonary infiltrates. Chest X-ray usually shows patchy infiltrates, and single 
or multiple foci of consolidation.25 
On microscopic examination, the hyphae of mucormycosis are broad (6-25µm or more wide), 
delicate thin-walled, aseptate, pleomorphic with irregular non-parallel contours. The branching 
is often irregular arising at right angles to the parent hyphae. The hyphae are often wrinkled 
and folded upon themselves. The fungal infection is characterized by coagulative necrosis, 
neutrophilic infiltration and rarely granulomatous reaction. Angioinvasion leads to 
disseminated infection and ischemic necrotic lesions and infarcts. Amphotericin B is the drug of 
choice. 
4.3 Cryptococcosis 
Cryptococcosis starts as lung infection acquired by inhalation of the soil-inhabiting yeast, 
Crytococcus neoformans.26,27 The fungus is ubiquitous and is especially abundant in aviun, 
particularly pigeon excreta.28,29 Although the disease occurs in apparently healthy 
individuals, it is more often seen as an opportunistic infection especially in patients with 
haematologic malignancies, AIDS or patients with defective cellular immunity.30 
The pulmonary lesions include diffuse miliary lesions or patchy consolidation of mucoid 
nature, which is appreciable in freshly sectioned lungs. On microscopy, cryptococci are of 
variable size (5-15 m in diameter) present both intra as well as extracellularly. These are 
ovoid, thin-walled, encapsulated organisms surrounded by a wide, clear capsule and have 
narrow-based budding (figure 6). This infection may be accompanied by little or no 
inflammation, a mixed inflammatory response or a granulomatous reaction. The capsule 
of these organisms is highlighted on PAS-AB (PAS- Alcain blue) or mucicarmine stains.31 
Autofluorescence microscopy in Papanicolaou-stained smears gives auto fluorescence, 
which helps in rapid diagnosis of cryptococosis.32 Cryptococci should be differentiated 
from Blastomycosis, Histoplasma capsulatum, and Coccidiodes immitis. The combination of 
amphotericin B and 5-fluorocytosine is used for progressive pulmonary cryptococcosis. 
4.4 Histoplasmosis 
Histoplasmosis is a pulmonary disease caused by inhalation of airborne infectious conidia of 
the dimorphic fungus, Histoplasma capsulatum var. capsulatum.33 Avian habitat like chicken  
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Fig. 6. Extra cellular organisms of Cryptococcus; about 5-15 m in diameter with budding 
(MGG, 100X) 
coops, blackbird roosts, and caves, favor growth and multiplication of the fungus in soil rich 
in faecal matter. The clinical presentation depends upon the extent of exposure, presence of 
underlying pulmonary disease and the host immune status. Majority of the infections are 
asymptomatic. Symptomatic infection occurs in about 10-25% cases and these can be acute 
pulmonary disease, disseminated disease, chronic pulmonary disease and fibrosing 
mediastinitis. The confirmation of the recent or past infection is done by a positive reaction 
to the cutaneous test antigen histoplasmin.  
Acute pulmonary disease 
The patients may be asymptomatic or develop influenza-like symptoms after an incubation 
period of about 15 days. Pathologically, the lesion shows bronchopneumonia with 
neutrophilic infiltration, along with macrophages, lymphocytes, and plasma cells. 
Granulomatous reaction with multinucleated giant cells occurs after two weeks followed by 
caseous necrosis.34 
Disseminated disease 
Disseminated Histoplasmosis occurs in patients with defective cell mediated immunity and 
it leads to spread to infection to multiple organs.  The patients present with fever with chills, 
productive cough, hemoptysis, dyspnea, weight loss, headache, drowsiness, diarrhea, 
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generalized lymphadenopathy, hepatosplenomegaly, purpura, and intestinal ulcerations. 
Chest X-ray usually reveals diffuse pulmonary interstitial infiltrates.35 The fungi may be 
associated with granulomatous reaction and the necrotic lesions may calcify. 
Chronic pulmonary Histoplasmosis 
Radiologically, the lesions can be infiltrative, cavitary, fibrosis with emphysema, and the 
residual solitary nodule or histoplasmoma (coin lesion).35 Other findings can be military 
calcification, pleural thickening, and enlarged hilar nodes. 
Fibrosing mediastinitis 
It is a benign condition comprising of fibrosis/ collagenization in mediastinum.36 The 
patients present with cough, dyspnea, hemoptysis, and pleurisy. Extensive fibrosis may lead 
to entrapment of heart or great vessels rarely. 
The organisms are yeast like spherical or oval, uniform, 2- 4µm in diameter organisms, 
which reproduce by single budding (figure 7).37 The basophilic cytoplasm of the organism is 
retracted from rigid, thin, poorly stained cell wall, creating a halo/ clear space. The 
organisms are seen mainly within the macrophages. This may be associated with intense 
granulomatous reaction with caseation necrosis or calcification, which can mimic 
tuberculosis. The cell wall intensely stains with special stains especially Gomori 
methenamine silver stain. Gridley, PAS and Haematoxylin & Eosin stains do not reliably 
demonstrate these organisms. 
 
Fig. 7. Extracellular as well as intracellular round to oval, 2-4µm in size, budding yeasts of 
Histoplasma (MGG, 100X) 
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Differential diagnosis- The differential diagnosis of Histoplasma capsulatum includes 
Cryptococcus neoformans, Candida glabrata, Coccidiodes immitis, Blastomycosis dermatitidis and 
Leishmania amastigotes.37 
4.5 Blastomycosis 
Blastomycosis is a systemic infection caused by the dimorphic fungus, Blastomyces dermatitidis. 
The infection is acquired by inhalation of airborne conidia of the mycelial form forming a 
pulmonary focus of infection. The pulmonary involvement can be acute or chronic. Acute 
pulmonary blastomycosis is usually a self-limited illness and the patient may remain 
asymptomatic or have non-specific symptoms varying from mild influenza-like symptoms to 
pneumonia. Chest X-ray shows patchy areas of consolidation with involvement of posterior 
segments of lower lobes of lungs in majority of the cases. The patients with chronic 
blastomycosis present with chronic respiratory symptoms such as chronic cough and chest 
pain persisting for weeks or months.38 Chest X-ray show linear lung infiltrates, mediastinal 
lymphadenopathy and pulmonary nodules with cavitation mimicking tuberculosis.39 Multiple 
organ involvement occurs involving skin, bone and genitourinary tract. 
The infection is acquired by inhalation of conidia from woody plant matter. The mold form 
is transformed into the yeast form in distal airways. In smears or tissue sections, the yeast is 
seen intra as well as extracellularly in macrophages and polymorphs. The organism may 
elicit acute abscess like reaction with neutrophilic infiltration to granulomatous reaction 
with epithelioid granulomas and multinucleated giant cells. The organisms are round to 
oval, 8-15µm in diameter with thick refractile double contoured walls and single broad 
based budding. The differential diagnosis includes H. capsulatum, Cryptococcus and 
Coccidioides immitis. 
4.6 Coccidioidomycosis 
It is caused by the dimorphic fungus, Coccidioides immitis. It is endemic in the southwest 
United States40 and north and central Mexico. Pulmonary infection is acquired by inhalation 
of airborne arthroconidia. The patients may remain asymptomatic or develop influenza-like 
illness, which is self-limiting. Chronic pneumonia, destructive fibro-cavitary disease or 
disseminated infection occurs in minority of the patients. Pulmonary lesions can be 
pneumonic, cavitary, nodulo-caesous and bronchiectatic.41 Pulmonary lesions are usually 
associated with acute suppurative or granulomatous inflammation. The organisms are thin-
walled, mature spherules, 30-200µm in diameter (figure 8). Rupture of the spherules releases 
endospores into the surrounding tissue. The differential diagnosis includes sporangia of 
Rhinosporidium seeberi, budding yeast of Blastomyces dermatitidis or Histoplasma capsulatum. 
4.7 Paracoccidioidomycosis (South American blastomycosis) 
It is a chronic progressive lung infection caused by Paracoccidioides brasiliensis and is endemic 
in South America. Pulmonary infection may be acute progressive with acute suppurative 
pneumonia or chronic progressive infection with granulomatous inflammation. The 
organisms are pleomorphic yeast like, 5-60µm in diameter, reproducing by budding. Yeast 
cells with fractured walls called mosaic cells are seen in chronic pulmonary lesions. The 
characteristic multiple budding cells give the appearance of a ship’s steering wheel. The  
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Fig. 8. Thin- walled (30-200µm in diameter) mature spherule of coccidiomycosis (MGG 
x20X) 
blastoconidia produced by these cells can have an oval, tubular appearance or tear-drop 
blastoconidia attached to the parent cell by narrow necks. This needs to be differentiated 
from Histoplasma capsulatum. 
4.8 Candidiasis 
Candidiasis comprises of superficial, mucocutaneous, or systemic fungal infection caused by 
yeast like fungi of the genus Candida. Candida albicans is the most common type. Pulmonary 
involvement can be a) endobronchial/ primary pulmonary candidiasis acquired by 
aspiration of Candida spp. from oral cavity or upper respiratory tract, b) hematogenous 
pulmonary candidiasis and c) embolic pulmonary candidiasis in children with indwelling 
venous catheters.42,43 The lesions contain yeast forms and mycelial forms of Candida. The 
yeast-like cells are round to oval, 2-6µm in diameter, and have budding. The mycelia forms 
have both pseudohyphae and true septate branched hyphae. Pseudohyphae have periodic 
constrictions at the point where budding yeast cells are joined end to end. The inflammatory 
response to candida may vary from minimal inflammation to acute suppuration to 
granulomatous inflammation in chronic infections. The differential diagnosis includes B. 
dermatitidis, C. neoformans, H. capsulatum, and S. schenckii, the tissue forms of these consist of 
yeast forms. 
4.9 Pneumocystis jeroveci 
This is commonly seen in AIDS patients.44 Microscopically, the alveoli are usually filled with 
frothy, eosinophilic, PAS-positive coagulum in which the shadows of the non-staining cysts 
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are seen. Grocott’s Methenamine Silver (GMS) stain is used and the cell wall of the cyst 
stains black, often with a central dark dot. The cysts are 4 to 6 μm in diameter and spherical 
or cup/ sickle-shaped. Trophozoites may be up to 8 per cyst, are about 0.5 to 1.0μm in 
diameter and stain in Romanowsky (tiny purple dots). The diagnosis may be made on 
sputum or bronchoalveolar lavage fluid by demonstrating the cysts. 
5. Bacterial infections that resemble fungal infections 
5.1 Nocardiosis 
Nocardiosis is a localized or disseminated infection caused by aerobic, filamentous, 
branching gram-positive bacteria.45 It is an uncommon infection in immunocompetent 
hosts. Pulmonary lesions may be large cavitating abscesses or diffuse fibrino-suppurative 
pneumonia. The smears or tissue sections show thin (about 1µm wide), filamentous, 
beaded bacilli branching at approximately right angles (figure 9).46 These are usually 
obscured by an intense acute necrotizing inflammation as they remain unstained on May-
Grünwald Geimsa (MGG) stain, Haematoxylin or Eosin (H&E) or PAS stains. The special 
stain used for its confirmation is a modified Ziehl- Neelsen stain using a weak 
decolorizing agent.47 The main differential diagnosis is Mycobacterium tuberculosis and 
Actinomycosis (figure 10).  
 
Fig. 9. Multiple long thin filamentous structures (Nocardia) in an inflammatory background 
(Modified Ziehl- Neelsen stain, 100X). 
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Fig. 10. Filamentous bacilli positive on Gram’s stain of Actinomycosis (MGG x40X; Inset- 
Gram stain- 40X). 
5.2 Botryomycosis (Bacterial pseudomycosis) 
It is a chronic, localized infection of the skin and subcutaneous tissue or various organs 
including lung and brain.48 It is caused by non-filamentous bacilli that form granules which 
include Pseudomonas aeruginosa, Staphylococcus aureus, Escherichia coli or Streptococci. 
Pulmonary lesions lead to acute suppurative abscesses with multiple granules which are 
bordered by eosinophillic, club-like Splendore-Hoeppli material. The differential diagnosis 
includes nocardiosis and actinomycosis.  
6. Primary atypical pneumonia 
Mycoplasma pneumoniae & Chlamydiae are the important causes of primary atypical 
pneumonia. Mycoplasma can be stained by Giemsa but not by Gram’s stain and the 
diagnosis is usually confirmed serologically. Microscopically, a prominent interstitial 
infiltrate of lymphocytes, histiocytes and plasma cells is seen with interstitial oedema.  
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Pulmonary infections are notorious in causing considerable morbidity and mortality. Caused by bacteria,
viruses or fungi, respiratory infections require distinct knowledge of recent advances in pathogenesis. Progress
in the understanding of immunopathogenesis of Acinetobacter baumannii infection will explain how an atypical
organism establishes infection. The chapter regarding pulmonary nontuberculous mycobacterial infections in
the State of Para depicts a unique study in an endemic region for tuberculosis in North of Brazil. The diagnosis
and treatment of latent tuberculosis is a formidable challenge. Thus, new developments in diagnosis and
treatment of latent tuberculosis are included in this book. Challenging in their diagnosis, nontuberculous
mycobacterial pulmonary diseases require special education for management. The problems of respiratory
infections in the immunocompromised host are increasing in numbers and in resilience to treatment.
Therefore, the chapter describing the host immune responses against pulmonary fungal pathogens comes as
a necessary section in this book. The insight brought forth from this book can be valuable for both clinicians
and scientists.
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